Real-world evidence of cabozantinib in patients with metastatic renal cell carcinoma: Results from the CABOREAL Early Access Program.
暂无分享，去创建一个
B. Escudier | S. Oudard | G. Gravis | P. Barthélémy | S. Ladoire | A. Thiery-Vuillemin | A. Fléchon | C. Chevreau | L. Albiges | V. Perrot | B. Laguerre | L. Geoffrois | M. Gross-goupil | J. Tourani | É. Meriaux | D. Topart | A. Flechon | Anaïs Billard | M. Gross‐Goupil | M. Gross-Goupil